Literature DB >> 14092955

TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATE.

L E HUGHES.   

Abstract

Keywords:  ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, EPIDERMOID; DOSAGE FORMS; GERIATRICS; HODGKIN'S DISEASE; LUNG NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; PROTAMINES; SKIN NEOPLASMS; THYROID NEOPLASMS; TOES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14092955     DOI： 10.1016/s0140-6736(64)92787-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Identification of a plasminogen activator derived from nasopharyngeal carcinoma.

Authors:  T Kosugi; G W Huang; M Nakamura; S Koja; H T Nong
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Protamine sulfate-induced enzyme secretion from rabbit neutrophils.

Authors:  J G Elferink; M Deierkauf
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

Review 3.  Tumour angiogenesis.

Authors:  F Arnold
Journal:  Ann R Coll Surg Engl       Date:  1985-09       Impact factor: 1.891

4.  Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

Authors:  Sophie Le Gonidec; Carline Chaves-Almagro; Yushi Bai; Hye Jin Kang; Allyson Smith; Estelle Wanecq; Xi-Ping Huang; Hervé Prats; Bernard Knibiehler; Bryan L Roth; Larry S Barak; Marc G Caron; Philippe Valet; Yves Audigier; Bernard Masri
Journal:  FASEB J       Date:  2017-02-27       Impact factor: 5.191

5.  Enhancement of anti-tumour effect by cooling.

Authors:  J P Austin; E M Glaser
Journal:  Int J Biometeorol       Date:  1969-10       Impact factor: 3.787

6.  Protamine inhibits adenylate cyclase activity: a possible reason for the toxicity of protamine.

Authors:  Z Kiss; R Zamfirova
Journal:  Experientia       Date:  1983-12-15

7.  Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man.

Authors:  S A Cederholm-Williams; A King; M J Allington; P G Gill; A A Sharp; B J Britton
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.